Yun-Long Shen1, He-Zhen Li1, Yan-Wei Hu2, Lei Zheng2, Qian Wang2. 1. Department of Neurosurgery, The Fifth Affiliated Hospital, South Medical University, Guangzhou, China. 2. Clinical Laboratory Department, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Abstract
AIMS: In this study, we examined the expression of GINS2 in glioma and determined its role in glioma development. METHODS: The protein expression of GINS2 was assessed in 120 human glioma samples via immunohistochemistry. Then, we suppressed the expression of GINS2 in glioma cell strains U87 and U251 using a short hairpin RNA lentiviral vector. In addition, RNA sequencing and bioinformatics analysis were performed on glioma cells before and after GINS2 knockdown. Subsequent co-immunoprecipitation and western blot experiments indicated possible downstream regulatory molecules. RESULTS: The present results showed that GINS2 can accelerate the growth of glioma cells, whereas the suppression of GINS2 expression decreased the proliferation and tumorigenicity of glioma cells. Mechanism research experiments proved that GINS2 can block the cell cycle by regulating certain downstream molecules, such as MCM2, ATM, and CHEK2. CONCLUSION: GINS2 is closely related to the occurrence and development of glioma, and is likely to become a prognostic marker for glioma patients, as well as a potential therapeutic target in the treatment of glioma.
AIMS: In this study, we examined the expression of GINS2 in glioma and determined its role in glioma development. METHODS: The protein expression of GINS2 was assessed in 120 humanglioma samples via immunohistochemistry. Then, we suppressed the expression of GINS2 in glioma cell strains U87 and U251 using a short hairpin RNA lentiviral vector. In addition, RNA sequencing and bioinformatics analysis were performed on glioma cells before and after GINS2 knockdown. Subsequent co-immunoprecipitation and western blot experiments indicated possible downstream regulatory molecules. RESULTS: The present results showed that GINS2 can accelerate the growth of glioma cells, whereas the suppression of GINS2 expression decreased the proliferation and tumorigenicity of glioma cells. Mechanism research experiments proved that GINS2 can block the cell cycle by regulating certain downstream molecules, such as MCM2, ATM, and CHEK2. CONCLUSION:GINS2 is closely related to the occurrence and development of glioma, and is likely to become a prognostic marker for gliomapatients, as well as a potential therapeutic target in the treatment of glioma.
Authors: Ming Zheng; Yinghui Zhou; Xiangmin Yang; Juan Tang; Ding Wei; Yang Zhang; Jian-Li Jiang; Zhi-Nan Chen; Ping Zhu Journal: Breast Cancer Res Treat Date: 2014-10-28 Impact factor: 4.872
Authors: Yingyu Sun; Wei Zhang; Dongfeng Chen; Yuhong Lv; Junxiong Zheng; Henrik Lilljebjörn; Liang Ran; Zhaoshi Bao; Charlotte Soneson; Hans Olov Sjögren; Leif G Salford; Jianguang Ji; Pim J French; Thoas Fioretos; Tao Jiang; Xiaolong Fan Journal: Proc Natl Acad Sci U S A Date: 2014-02-18 Impact factor: 11.205
Authors: Chuan He Yang; Yinan Wang; Michelle Sims; Chun Cai; Ping He; Hans Häcker; Junming Yue; Jinjun Cheng; Frederick A Boop; Lawrence M Pfeffer Journal: Oncotarget Date: 2017-12-06
Authors: Yao Zhang; Xiaopei Hao; Guoyong Han; Yiwei Lu; Zhiqiang Chen; Long Zhang; Jindao Wu; Xuehao Wang Journal: Am J Cancer Res Date: 2022-04-15 Impact factor: 5.942